KT Tape for Pediatric Clavicle Fractures
Launched by UNIVERSITY OF ALABAMA AT BIRMINGHAM · Nov 11, 2019
Trial Information
Current as of July 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the use of KT Tape, a type of elastic tape, to help treat clavicle fractures in children. Normally, when children break their collarbone, doctors use a sling to keep it still while it heals. While this method works well—most fractures heal successfully—children often experience pain and difficulty moving during the healing process. The trial aims to see if using KT Tape can provide better support and comfort, potentially leading to less pain and quicker recovery.
To participate in the trial, children aged 2 to 17 who have recently broken their collarbone (within the last week) can enroll. However, children with certain conditions, like muscle or bone disorders, or those who can’t report their pain levels, won't be eligible. Participants will receive either the KT Tape treatment or standard care with a sling and will be monitored for their pain and healing progress. This study is important because it could help improve how clavicle fractures are treated, making recovery easier for kids.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Clavicle Fracture
- • Injury date within 1 week of presentation
- Exclusion Criteria:
- • Underlying neuromuscular disorder (eg osteogenesis imperfecta)
- • Inability or unwillingness to report pain score until healing
About University Of Alabama At Birmingham
The University of Alabama at Birmingham (UAB) is a prominent academic institution and research hub dedicated to advancing healthcare through innovative clinical trials. Renowned for its commitment to medical discovery and education, UAB conducts cutting-edge research across a wide array of disciplines, including oncology, cardiology, neurology, and public health. With a robust infrastructure for clinical research, UAB fosters collaboration among interdisciplinary teams, leveraging state-of-the-art facilities and resources to enhance the translation of scientific findings into effective treatments and interventions. As a leader in clinical research, UAB aims to improve patient outcomes and contribute to the broader medical community through rigorous trial design and implementation.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Birmingham, Alabama, United States
Patients applied
Trial Officials
Shawn R Gilbert, MD
Principal Investigator
University of Alabama at Birmingham
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials